FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

385114002: Prolonged-release transdermal patch (dose form)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-Jul 2024. Module: IPS terminology module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
3634738017 Prolonged-release transdermal patch (dose form) en Fully specified name Active Entire term case insensitive (core metadata concept) IPS terminology module (core metadata concept)
3634739013 Prolonged-release transdermal patch en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) IPS terminology module (core metadata concept)


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Prolonged-release transdermal patch (dose form) Is a Qualifier value true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Buprenorphine 20 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Nicotine 291.667 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Buprenorphine 35 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Product containing precisely buprenorphine 70 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Product containing precisely fentanyl 100 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Product containing precisely fentanyl 50 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Nicotine 625 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Product containing precisely fentanyl 25 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Nicotine 583.333 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Product containing precisely nicotine 312.5 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Hyoscine 13.889 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Fentanyl 12 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Product containing precisely nicotine 937.5 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Product containing precisely buprenorphine 52.5 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Product containing precisely fentanyl 75 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Product containing precisely nicotine 875 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some
Buprenorphine 10 microgram/hour prolonged-release transdermal patch Has manufactured dose form True Prolonged-release transdermal patch (dose form) Inferred relationship Some

This concept is not in any reference sets

Back to Start